These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 25257204
1. Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms. Ozbek B, Mataraci-Kara E. J Chemother; 2016; 28(1):20-4. PubMed ID: 25257204 [Abstract] [Full Text] [Related]
2. In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains. Ozbek B, Mataraci E. J Antimicrob Chemother; 2013 Apr; 68(4):827-30. PubMed ID: 23203948 [Abstract] [Full Text] [Related]
3. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. Lee MY, Ko KS, Song JH, Peck KR. J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978 [Abstract] [Full Text] [Related]
4. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence In Vitro-Impairment of Secretory Profile and Biofilm Production onto Peritoneal Dialysis Catheters. Colombari B, Alfano G, Gamberini C, Cappelli G, Blasi E. Microbiol Spectr; 2021 Dec 22; 9(3):e0104721. PubMed ID: 34787464 [Abstract] [Full Text] [Related]
5. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. Lebeaux D, Chauhan A, Létoffé S, Fischer F, de Reuse H, Beloin C, Ghigo JM. J Infect Dis; 2014 Nov 01; 210(9):1357-66. PubMed ID: 24837402 [Abstract] [Full Text] [Related]
6. Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model. Mataraci Kara E, Ozbek Celik B. J Chemother; 2018 Apr 01; 30(2):82-88. PubMed ID: 29063819 [Abstract] [Full Text] [Related]
7. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria. Luther MK, Mermel LA, LaPlante KL. Am J Health Syst Pharm; 2017 May 01; 74(9):e193-e201. PubMed ID: 28438824 [Abstract] [Full Text] [Related]
8. Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms. Passerini de Rossi B, Feldman L, Pineda MS, Vay C, Franco M. J Med Microbiol; 2012 Sep 01; 61(Pt 9):1248-1253. PubMed ID: 22580911 [Abstract] [Full Text] [Related]
9. Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK. Nephrol Dial Transplant; 2009 Jun 01; 24(6):1937-45. PubMed ID: 19181762 [Abstract] [Full Text] [Related]
10. Antibiotic Lock Therapy in the Era of Gram-Negative Resistance. Soman R, Gupta N, Suthar M, Kothari J, Almeida A, Shetty A, Rodrigues C. J Assoc Physicians India; 2016 Feb 01; 64(2):32-37. PubMed ID: 27730778 [Abstract] [Full Text] [Related]
11. Generalized and Prolonged Use of Gentamicin-Lock Therapy Reduces Hemodialysis Catheter-Related Infections Due to Gram Negatives. Padilla-Orozco M, Mendoza-Flores L, Herrera-Alonso A, Garza González E, Gutiérrez Ferman JL, Rodríguez-López JM, Bocanegra-Ibarias P, Camacho-Ortiz A. Nephron; 2019 Feb 01; 143(2):86-91. PubMed ID: 31203289 [Abstract] [Full Text] [Related]
12. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Ann Pharmacother; 2009 Feb 01; 43(2):210-9. PubMed ID: 19193593 [Abstract] [Full Text] [Related]
13. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Chauhan A, Lebeaux D, Ghigo JM, Beloin C. Antimicrob Agents Chemother; 2012 Dec 01; 56(12):6310-8. PubMed ID: 23027191 [Abstract] [Full Text] [Related]
14. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. Lebeaux D, Leflon-Guibout V, Ghigo JM, Beloin C. J Antimicrob Chemother; 2015 Dec 01; 70(6):1704-12. PubMed ID: 25712314 [Abstract] [Full Text] [Related]
15. Prevention and Treatment of Pseudomonas Aeruginosa-Based Biofilm with Ethanol. Natan M, Jacobi G, Banin E, Ashkenazi S. Isr Med Assoc J; 2020 May 01; 22(5):299-302. PubMed ID: 32378822 [Abstract] [Full Text] [Related]
16. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains. Kádár B, Szász M, Kristóf K, Pesti N, Krizsán G, Szentandrássy J, Rókusz L, Nagy K, Szabó D. Acta Microbiol Immunol Hung; 2010 Sep 01; 57(3):235-45. PubMed ID: 20870595 [Abstract] [Full Text] [Related]
18. The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection. Wang Y, Li C, Wang J, Bai N, Zhang H, Chi Y, Cai Y. Microbiol Spectr; 2022 Oct 26; 10(5):e0146822. PubMed ID: 36102678 [Abstract] [Full Text] [Related]
19. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. Saini H, Vadekeetil A, Chhibber S, Harjai K. Antimicrob Agents Chemother; 2017 Mar 26; 61(3):. PubMed ID: 28031194 [Abstract] [Full Text] [Related]
20. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar 26; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]